reference/20246055

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20246055

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	185
issn	0920-1211
pageRange	179-185
publicationName	Epilepsy Research
startingPage	179
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5471a71fa537c489e48d1bf84083eef2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a0c77b1373e914b0a28e8883bf3ec4d1
bibliographicCitation	Moseley BD, Sperling MR, Asadi-Pooya AA, Diaz A, Elmouft S, Schiemann J, Whitesides J. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies. Epilepsy Res. 2016 Nov;127():179–85. doi: 10.1016/j.eplepsyres.2016.09.003. PMID: 27608437.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a18865b799ffc63b524f65a17d12dca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ae05103680e026e1262024c23073801 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b202029b64fcd6e00bc825e6b130528a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcd171863cfcfb58c05bc71a6168d857 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abb62b10419ff07f27a8c03f9597ac09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8573-7340 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_493f6c38132e71c716368a6233c83cce
date	201611
identifier	https://doi.org/10.1016/j.eplepsyres.2016.09.003 https://pubmed.ncbi.nlm.nih.gov/27608437
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies
discusses	http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0497062 http://id.nlm.nih.gov/mesh/M0018278
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D012640Q000188 http://id.nlm.nih.gov/mesh/D000069279Q000188 http://id.nlm.nih.gov/mesh/D011760Q000627 http://id.nlm.nih.gov/mesh/D000927Q000627 http://id.nlm.nih.gov/mesh/D004830Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000927Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011760Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7620 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9837243 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191

Total number of triples: 54.